Difficulty: Medium
Average Score: 87%
Practice
You are called to administer a nebulized albuterol treatment to a 47-year-old female patient that is receiving oxygen via binasal cannula at 2 L/min. Her pretreatment heart rate was recorded at 84 beats/min. You would stop the treatment if the patient's heart rate were to reach which of the following:
Correct answer
D
Rationale
In this scenario, the correct answer is D) 119 beats/min. When administering nebulized albuterol, it is crucial to monitor the patient's heart rate as it can be a potential side effect of the medication. Albuterol is a beta-2 adrenergic agonist that can lead to tachycardia as a result of its stimulatory effects on beta receptors in the heart.
Choosing option D as the threshold to stop the treatment is appropriate because a heart rate of 119 beats/min indicates a significant increase from the baseline heart rate of 84 beats/min. This level of tachycardia can be concerning and may warrant discontinuation of the albuterol treatment to prevent further cardiac complications.
Regarding why the other options are incorrect:
- Option A) 89 beats/min: This heart rate increase may not be significant enough to warrant stopping the treatment and may not indicate a serious adverse reaction.
- Option B) 99 beats/min: While closer to the correct answer, it still may not represent a significant enough increase in heart rate to pose immediate risks.
- Option C) 109 beats/min: Similar to B, this heart rate elevation may not be high enough to justify halting the treatment.
From an educational perspective, understanding the potential side effects of respiratory medications like albuterol and knowing how to monitor and respond to changes in vital signs is crucial for healthcare providers. This case emphasizes the importance of close monitoring during drug administration to ensure patient safety and well-being.
Choosing option D as the threshold to stop the treatment is appropriate because a heart rate of 119 beats/min indicates a significant increase from the baseline heart rate of 84 beats/min. This level of tachycardia can be concerning and may warrant discontinuation of the albuterol treatment to prevent further cardiac complications.
Regarding why the other options are incorrect:
- Option A) 89 beats/min: This heart rate increase may not be significant enough to warrant stopping the treatment and may not indicate a serious adverse reaction.
- Option B) 99 beats/min: While closer to the correct answer, it still may not represent a significant enough increase in heart rate to pose immediate risks.
- Option C) 109 beats/min: Similar to B, this heart rate elevation may not be high enough to justify halting the treatment.
From an educational perspective, understanding the potential side effects of respiratory medications like albuterol and knowing how to monitor and respond to changes in vital signs is crucial for healthcare providers. This case emphasizes the importance of close monitoring during drug administration to ensure patient safety and well-being.